Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | 5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled | Starlite/ChEMBL | References |
Cavia porcellus | 3-beta-hydroxysteroid-delta(8),delta(7)-isomerase | Starlite/ChEMBL | References |
Cavia porcellus | Sigma-1 receptor | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Trypanosoma cruzi | 3-Beta-hydroxysteroid-delta(8), delta(7)-isomerase, putative | 3-beta-hydroxysteroid-delta(8),delta(7)-isomerase | 229 aa | 213 aa | 21.6 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0317 | 0.6953 | 0.6953 |
Schistosoma mansoni | DNA topoisomerase II | 0.0125 | 0.2374 | 0.2504 |
Loa Loa (eye worm) | hypothetical protein | 0.0055 | 0.0704 | 0.0704 |
Leishmania major | hypothetical protein, conserved | 0.0166 | 0.3347 | 0.3347 |
Leishmania major | DNA topoisomerase ii | 0.0113 | 0.2073 | 0.2073 |
Loa Loa (eye worm) | hypothetical protein | 0.0055 | 0.0704 | 0.0704 |
Trypanosoma cruzi | DNA topoisomerase II, putative | 0.0113 | 0.2073 | 0.2073 |
Chlamydia trachomatis | DNA gyrase subunit B | 0.0068 | 0.1005 | 1 |
Schistosoma mansoni | amine GPCR | 0.0423 | 0.9482 | 1 |
Trypanosoma brucei | DNA topoisomerase II beta, putative | 0.0113 | 0.2073 | 0.2073 |
Echinococcus granulosus | DNA topoisomerase 2 alpha | 0.0125 | 0.2374 | 0.3415 |
Treponema pallidum | DNA gyrase, subunit B (gyrB) | 0.0041 | 0.0365 | 0.5 |
Leishmania major | C-8 sterol isomerase-like protein | 0.0445 | 1 | 1 |
Trypanosoma brucei | DNA topoisomerase ii | 0.0099 | 0.1734 | 0.1734 |
Trypanosoma cruzi | mitochondrial DNA topoisomerase II, putative | 0.0099 | 0.1734 | 0.1734 |
Entamoeba histolytica | DNA topoisomerase II, putative | 0.0125 | 0.2374 | 1 |
Plasmodium vivax | DNA topoisomerase II, putative | 0.0125 | 0.2374 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0084 | 0.1389 | 0.1389 |
Echinococcus multilocularis | DNA topoisomerase 2 alpha | 0.0125 | 0.2374 | 0.3415 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.002 | 0.002 |
Brugia malayi | Cytochrome P450 family protein | 0.0027 | 0.0015 | 0.0015 |
Trypanosoma brucei | DNA topoisomerase II alpha, putative | 0.0113 | 0.2073 | 0.2073 |
Trypanosoma cruzi | C-8 sterol isomerase, putative | 0.0445 | 1 | 1 |
Brugia malayi | DNA gyrase/topoisomerase IV, A subunit family protein | 0.0125 | 0.2374 | 0.2374 |
Loa Loa (eye worm) | hypothetical protein | 0.0445 | 1 | 1 |
Echinococcus granulosus | biogenic amine 5HT receptor | 0.0317 | 0.6953 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.002 | 0.002 |
Trypanosoma brucei | C-8 sterol isomerase, putative | 0.0445 | 1 | 1 |
Echinococcus multilocularis | serotonin receptor | 0.0317 | 0.6953 | 1 |
Onchocerca volvulus | 0.0166 | 0.3347 | 1 | |
Trypanosoma cruzi | mitochondrial DNA topoisomerase II, putative | 0.0099 | 0.1734 | 0.1734 |
Brugia malayi | Probable DNA topoisomerase II | 0.0125 | 0.2374 | 0.2374 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.002 | 0.002 |
Trypanosoma cruzi | 3-Beta-hydroxysteroid-delta(8), delta(7)-isomerase, putative | 0.0166 | 0.3347 | 0.3347 |
Schistosoma mansoni | biogenic amine (5HT) receptor | 0.0317 | 0.6953 | 0.7333 |
Plasmodium falciparum | DNA gyrase subunit B | 0.0041 | 0.0365 | 0.1539 |
Trypanosoma cruzi | Emopamil binding protein, putative | 0.0166 | 0.3347 | 0.3347 |
Trichomonas vaginalis | DNA topoisomerase II, putative | 0.0125 | 0.2374 | 1 |
Trypanosoma cruzi | 3-Beta-hydroxysteroid-delta(8), delta(7)-isomerase, putative | 0.0166 | 0.3347 | 0.3347 |
Plasmodium vivax | DNA gyrase subunit B, putative | 0.0041 | 0.0365 | 0.1539 |
Plasmodium falciparum | DNA topoisomerase 2 | 0.0125 | 0.2374 | 1 |
Toxoplasma gondii | ATPase/histidine kinase/DNA gyrase B/HSP90 domain-containing protein | 0.0041 | 0.0365 | 0.1539 |
Trypanosoma cruzi | Emopamil binding protein, putative | 0.0166 | 0.3347 | 0.3347 |
Loa Loa (eye worm) | hypothetical protein | 0.0317 | 0.6953 | 0.6953 |
Loa Loa (eye worm) | TOPoisomerase family member | 0.0125 | 0.2374 | 0.2374 |
Mycobacterium tuberculosis | DNA gyrase (subunit B) GyrB (DNA topoisomerase (ATP-hydrolysing)) (DNA topoisomerase II) (type II DNA topoisomerase) | 0.0041 | 0.0365 | 0.5 |
Trypanosoma cruzi | DNA topoisomerase II, putative | 0.0113 | 0.2073 | 0.2073 |
Wolbachia endosymbiont of Brugia malayi | DNA gyrase, topoisomerase II, B subunit, GyrB | 0.0041 | 0.0365 | 0.5 |
Giardia lamblia | DNA topoisomerase II | 0.012 | 0.2242 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0227 | 0.4808 | 0.4808 |
Brugia malayi | DNA topoisomerase II, alpha isozyme | 0.0125 | 0.2374 | 0.2374 |
Mycobacterium ulcerans | DNA gyrase subunit B | 0.0041 | 0.0365 | 0.5 |
Trypanosoma brucei | Emopamil binding protein, putative | 0.0166 | 0.3347 | 0.3347 |
Leishmania major | mitochondrial DNA topoisomerase II | 0.0099 | 0.1734 | 0.1734 |
Leishmania major | 3-Beta-hydroxysteroid-delta(8), delta(7)-isomerase, putative | 0.0166 | 0.3347 | 0.3347 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0027 | 0.0015 | 0.0015 |
Loa Loa (eye worm) | hypothetical protein | 0.0084 | 0.1389 | 0.1389 |
Echinococcus multilocularis | serotonin receptor | 0.0317 | 0.6953 | 1 |
Toxoplasma gondii | DNA topoisomerase 2, putative | 0.0125 | 0.2374 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | < 10 % | Cytotoxicity against human PC3 cells assessed as LDH release at 100 uM after 24 hrs relative to untreated control | ChEMBL. | 19053780 |
Activity (binding) | = 30.4 % | Agonist activity at human 5-HT1A receptor expressed in CHO cells assessed as ERK1/2 phosphorylation at 1 uM after 5 mins by Western blot analysis relative to 5-HT | ChEMBL. | 26081758 |
EC50 (binding) | = 9.1 | Agonist activity at human 5-HT1A receptor expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation after 15 mins by ELISA | ChEMBL. | 26081758 |
EC50 (binding) | = 9.49 | Agonist activity at human 5-HT1A receptor expressed in CHO cells after 90 mins by beta-arrestin-2 recruitment assay | ChEMBL. | 26081758 |
Emax (binding) | = 27.9 % | Agonist activity at human 5-HT1A receptor expressed in CHO cells after 90 mins by beta-arrestin-2 recruitment assay relative to 5-HT | ChEMBL. | 26081758 |
Emax (binding) | = 69.5 % | Agonist activity at human 5-HT1A receptor expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation after 15 mins by ELISA relative to 5-HT | ChEMBL. | 26081758 |
Ki (binding) | = 0.028 nM | Agonist activity at human 5-HT1A receptor expressed in human HeLa cell membranes assessed as stimulation of [35S]GTPgammaS binding after 20 mins by liquid scintillation counting analysis | ChEMBL. | 26081758 |
Ki (binding) | = 16.2 nM | Displacement of [3H](-)-(S)-emopamil from EBP in guinea pig liver membrane | ChEMBL. | 19053780 |
Ki (functional) | = 23 nM | Antiproliferative activity against human PC3 cells expressing EBP after 48 hrs by MTT assay | ChEMBL. | 19053780 |
Ki (binding) | = 24.8 nM | Displacement of [3H](+)-pentazocine from sigma 1 receptor in guinea pig brain membrane without cerebellum | ChEMBL. | 19053780 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | 19053780 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.